Author:
Değirmencioğlu Serkan,demiray aydın,demiray atike gökçen,taskoylu burcu,doğu gamze gököz
Reference21 articles.
1. 1)Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. 2) Shim KN, Jung SA, Joo YH, Yoo K. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. J Gastroenterol 2007;42:120-128.
3. 3) Curran S, Murray GI. Matrix metalloproteinase in tumour invasion and metastasis. J Pathol 1999;189:300-308.
4. 4) Monig SP, Baldus SE, Hennecken JK, et al. Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology 2001;39:597-602.
5. 5) Passlick B, Sienel W, Seen-Hibler R, et al.Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 2000;6:3944-3948.